• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP2D6 缺失、扩增、-1584C-->G、31G-->A 和 2988G-->a 基因多态性对墨西哥特佩瓦诺人和梅斯蒂索人右美沙芬代谢的影响。

Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.

机构信息

Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional del IPN Unidad Durango, Durango, México.

出版信息

Pharmacology. 2010;86(1):30-6. doi: 10.1159/000314334. Epub 2010 Jun 30.

DOI:10.1159/000314334
PMID:20588073
Abstract

The aim of this study was to explain the variability of CYP2D6 activity by the identification of CYP2D6 deletion and multiplications, and the single-nucleotide polymorphisms (SNPs) -1584C-->G, 31G-->A and 2988G-->A in Mexican Mestizo and Tepehuano subjects. One hundred twelve Mestizos and 99 Tepehuano Amerindians were studied, who were previously phenotyped with dextromethorphan. The frequencies of CYP2D6*2A [-1584C-->G] and *35 [-1584C-->G, 31G-->A] were 10.7 and 4.1%, respectively, in Mestizos, which is evidently a trend towards an extensive metabolism in carriers of the -1584G change. In Tepehuanos, *2A was identified with a frequency of 20%, and the allele 35 was not found. The frequencies of CYP2D65 (deletion) and *41[2988G-->A] were 1.3 and 2.2% in Mestizos and 0.5 and 1% in Tepehuanos, respectively. The SNP 2988A was found to be significantly related with the intermediate metabolizer phenotype in Mestizos (R = 0.309; n = 88; p = 0.006). The multiplications had frequencies of 4.1% in Mestizos and 1.5% in Tepehuanos. Only in the Mestizos did the presence of multiplications significantly decrease the DM/DX (dextromethorphan/dextrorphan) values (R = 0.273; n = 88; p = 0.016). The polymorphisms studied had different frequencies between Tepehuanos and Mestizos (p < 0.001); however, in the Tepehuano group these had a low influence on their phenotypic expression. It helps to understand the genotype-phenotype relationships of CYP2D6 in our studied populations.

摘要

本研究的目的是通过鉴定 CYP2D6 缺失和倍增,以及单核苷酸多态性(SNP)-1584C-->G、31G-->A 和 2988G-->A,来解释 CYP2D6 活性的变异性。我们研究了 112 名梅斯蒂索人和 99 名特佩胡阿诺美洲印第安人,他们之前曾用右美沙芬进行表型检测。在梅斯蒂索人中,CYP2D62A[-1584C-->G]和35[-1584C-->G,31G-->A]的频率分别为 10.7%和 4.1%,这显然是携带-1584G 突变的广泛代谢的趋势。在特佩胡阿诺人中,2A 的频率为 20%,未发现等位基因35。CYP2D65(缺失)和41[2988G-->A]的频率在梅斯蒂索人中分别为 1.3%和 2.2%,在特佩胡阿诺人中分别为 0.5%和 1%。SNP 2988A 与梅斯蒂索人中的中间代谢表型显著相关(R = 0.309;n = 88;p = 0.006)。在梅斯蒂索人中,倍增的频率为 4.1%,在特佩胡阿诺人中为 1.5%。只有在梅斯蒂索人中,倍增的存在显著降低了 DM/DX(右美沙芬/右甲吗喃)值(R = 0.273;n = 88;p = 0.016)。在所研究的人群中,特佩胡阿诺人和梅斯蒂索人之间的多态性频率存在显著差异(p<0.001);然而,在特佩胡阿诺人群中,这些多态性对其表型表达的影响较低。这有助于我们理解研究人群中 CYP2D6 的基因型-表型关系。

相似文献

1
Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.CYP2D6 缺失、扩增、-1584C-->G、31G-->A 和 2988G-->a 基因多态性对墨西哥特佩瓦诺人和梅斯蒂索人右美沙芬代谢的影响。
Pharmacology. 2010;86(1):30-6. doi: 10.1159/000314334. Epub 2010 Jun 30.
2
CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.墨西哥杜兰戈州特佩瓦诺族裔美洲印第安人和梅斯蒂索人的CYP2D6基因分型与表型
J Clin Pharmacol. 2006 May;46(5):527-36. doi: 10.1177/0091270006287586.
3
CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.CYP2D6 基因多态性与来自墨西哥西北部的 8 个原住民群体的预测表型。
Pharmacogenomics. 2014 Feb;15(3):339-48. doi: 10.2217/pgs.13.203.
4
The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.CYP2D6基因多态性对墨西哥裔美国人右美沙芬代谢的影响。
J Clin Pharmacol. 2005 Nov;45(11):1230-5. doi: 10.1177/0091270005280755.
5
Phenotypical expression of CYP2D6 in amerindians of tepehuano origin from Durango, Mexico.来自墨西哥杜兰戈州特佩瓦诺族裔的美洲印第安人中CYP2D6的表型表达。
Proc West Pharmacol Soc. 2005;48:102-7.
6
Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.CYP2D6-1584C>G 多态性与硫利达嗪/美索达嗪血浆浓度比值在精神科患者中的相关性。
Pharmacogenomics. 2009 Jul;10(7):1083-9. doi: 10.2217/pgs.09.57.
7
Identification of CYP2D6 impaired functional alleles in Mexican Americans.墨西哥裔美国人中CYP2D6功能受损等位基因的鉴定。
Eur J Clin Pharmacol. 2005 Dec;61(11):797-802. doi: 10.1007/s00228-005-0044-4. Epub 2005 Nov 8.
8
Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.与代谢不良表型相关的CYP2D6和CYP2C19基因多态性在墨西哥五个美洲印第安人群体和西部混血人群中的分布。
Genet Test Mol Biomarkers. 2012 Sep;16(9):1098-104. doi: 10.1089/gtmb.2012.0055. Epub 2012 Aug 22.
9
Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.对墨西哥梅斯蒂索人的 CYP2D6 进行重测序、单倍型构建和新型变异体鉴定。
Pharmacogenomics. 2011 May;12(5):745-56. doi: 10.2217/pgs.11.8. Epub 2011 Mar 11.
10
Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.内含子单核苷酸多态性2988G>A导致携带*41等位基因的中间代谢者中CYP2D6表达受损:剪接事件调控的证据。
Pharmacogenet Genomics. 2006 Oct;16(10):755-66. doi: 10.1097/01.fpc.0000230112.96086.e0.

引用本文的文献

1
The Metabolization Profile of the Gene in Amerindian Populations: A Review.《基因在美洲印第安人群体中的代谢谱:综述》。
Genes (Basel). 2020 Feb 28;11(3):262. doi: 10.3390/genes11030262.
2
Frequency of Alleles Including Structural Variants in the United States.美国包括结构变异在内的等位基因频率
Front Pharmacol. 2018 Apr 5;9:305. doi: 10.3389/fphar.2018.00305. eCollection 2018.
3
P450 Pharmacogenetics in Indigenous North American Populations.北美原住民群体中的细胞色素P450药物遗传学
J Pers Med. 2018 Feb 1;8(1):9. doi: 10.3390/jpm8010009.
4
Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.新型药物代谢基因拷贝数变异导致药物药代动力学的个体间差异。
Genet Med. 2018 Jun;20(6):622-629. doi: 10.1038/gim.2017.156. Epub 2017 Oct 26.
5
CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.土耳其人群中CYP2C9、CYPC19和CYP2D6基因谱以及药物反应和毒性的基因易感性
Saudi Pharm J. 2017 Mar;25(3):376-380. doi: 10.1016/j.jsps.2016.09.003. Epub 2016 Sep 17.
6
High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies.西班牙CYP2D6超快代谢者的高频率:关于其在全球人群研究中错误分类的争议。
Pharmacogenomics J. 2016 Oct;16(5):485-90. doi: 10.1038/tpj.2016.47. Epub 2016 Jun 7.
7
Pharmacogenomic assessment of Mexican and Peruvian populations.墨西哥和秘鲁人群的药物基因组学评估。
Pharmacogenomics. 2015;16(5):441-8. doi: 10.2217/pgs.15.10.
8
Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.美国印第安人群体的药物遗传学:在科曼奇和克里族部落中对 CYP2D6、CYP3A4、CYP3A5 和 CYP2C9 的分析。
Pharmacogenet Genomics. 2013 Aug;23(8):403-14. doi: 10.1097/FPC.0b013e3283629ce9.
9
Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.与代谢不良表型相关的CYP2D6和CYP2C19基因多态性在墨西哥五个美洲印第安人群体和西部混血人群中的分布。
Genet Test Mol Biomarkers. 2012 Sep;16(9):1098-104. doi: 10.1089/gtmb.2012.0055. Epub 2012 Aug 22.
10
CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.厄瓜多尔人群 CYP2D6 基因型与右美沙芬羟化表型。
Eur J Clin Pharmacol. 2012 May;68(5):637-44. doi: 10.1007/s00228-011-1147-8. Epub 2011 Nov 15.